By blocking activity of the protein GSK-3 beta, the investigational therapy 9-ING-41 slowed disease progression and improved lung…
Alejandra Viviescas, PhD
Alejandra has a PhD in Genetics from São Paulo State University (UNESP) and is currently working as a scientific writer, editor, and translator. As a writer for BioNews, she is fulfilling her passion for making scientific data easily available and understandable to the general public. Aside from her work with BioNews, she also works as a language editor for non-English speaking authors and is an author of science books for kids.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alejandra Viviescas, PhD
Lab Model of Progressive Fibrosis Allows Scientists to Evaluate Therapeutic Candidates, Study Says
A novel lab model replicates the main steps leading to progressive fibrosis, and can be used to assess the properties…
Idebenone, an antioxidant molecule used to treat Alzheimer’s disease and other brain-damaging conditions, prevented lung damage in a…
Lung injuries caused during the progression of pulmonary fibrosis can lead to an increase in two inflammatory proteins, IL-6…
Pulmonary rehabilitation — a multidisciplinary intervention designed to manage the symptoms of different chronic lung diseases — may improve the…